Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (1 ops.)
Latest filing published 20 May 2024 for Alpine Immune Sciences, INC.. Read the official filing
Filing timeline
BuySaleRobert e. Conway
Insider track record
Disclosed buys
4
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert e. Conway: trading record in brief
Filings by Robert e. Conway span 2 companies, the busiest being Alpine Immune Sciences, Inc. and Oruka Therapeutics, Inc. In total, 6 filings cover trades dated from 5 May 2021 to 20 May 2024.
On the open market, the record shows 4 purchases worth €266k and 1 sale worth €129k. Netting one side against the other leaves €137k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €55k. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 20 May 2024: a transaction, in Alpine Immune Sciences, Inc. The clock since the last published purchase (27 September 2021) now reads 1,847 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert e. Conway
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 sharesCommon StockSEC:0001626199-24-000098:0
15,000 shares@ US$10.076918.9% of flowCommon StockSEC:0001626199-21-000130:0
Canonical exit: 22 Dec 2021 (T+90)
15,000 shares@ US$10.076960.6% of flowCommon StockSEC:0001626199-21-000127:0
10,000 shares@ US$9.796639.4% of flowCommon StockSEC:0001626199-21-000120:0
Canonical exit: 20 Dec 2021 (T+90)
10,000 shares@ US$3.194749.5% of flowCommon StockSEC:0001209191-21-032381:0
Canonical exit: 10 Aug 2021 (T+90)
10,000 shares@ US$3.234550.5% of flowCommon StockSEC:0001209191-21-030629:0
Canonical exit: 3 Aug 2021 (T+90)
6 of 6 declarations
